InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Jerman Michael Allen. Officer active across 2 companies, notably Inhibitor Therapeutics, Inc.. Aggregated, 7 reports have been logged. History available since 1 April 2024. The latest transaction was disclosed on 23 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Jerman Michael Allen is a declarant and a director at Inhibitor Therapeutics, Inc. (XNAS) and Alaunos Therapeutics, Inc. (XNAS). The record shows 4 filings, and across the recent filings tracked, the period runs from 2024-05-16 to 2026-06-24, with transaction nature shown as Attribution and a highest amount of 13370.37293632204 EUR.